Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

137
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
137
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.3K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

163
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
163
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

419
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
419

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the Korean Version of the Meta-Worry Questionnaire Among the General Population.

Psychiatry investigation·2026
Same author

AI-driven Medical Care: Evaluation of Large Language Models in Generating Personalized Stroke Education Materials.

Healthcare informatics research·2026
Same author

Machine-Learning Validated Short Form of the Korean Version of the Sleep-Related Behaviors Questionnaire-10 Items: SRBQ-10.

Behavioral sleep medicine·2025
Same author

Validation of the Korean Version of the Anxiety and Preoccupation About Sleep Questionnaire and Comparisons With Other Sleep-Related Cognition Scales Among the General Population.

Psychiatry investigation·2025
Same author

Development of the Adaptive Cognition and Behaviors about Sleep-6 (ACBS-6) for sleep-related conditions or behaviors diminishing insomnia severity.

Sleep medicine·2025
Same author

Effect of Psychological Inflexibility and Cancer-Related Dysfunctional Beliefs About Sleep on the Relationship Between Depression and Fear of Progression in Patients with Cancer.

The Psychiatric quarterly·2025
Same journal

RETRACTED: Meligy et al. Therapeutic Potential of Mesenchymal Stem Cells Versus Omega n - 3 Polyunsaturated Fatty Acids on Gentamicin-Induced Cardiac Degeneration. <i>Pharmaceutics</i> 2022, <i>14</i>, 1322.

Pharmaceutics·2026
Same journal

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same journal

Metal Nanoparticle-Reinforced Hydrogels Applied in the Inhibition of Clinical Pathogens: Structural Features, Mechanisms, and Biomedical Prospects.

Pharmaceutics·2026
Same journal

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.

Pharmaceutics·2026
Same journal

Artificial Intelligence in Nanopharmaceutical Development: From Predictive Design to Clinical Translation.

Pharmaceutics·2026
Same journal

Textilinin-1, a Snake Venom-Derived Kunitz-Type Protease Inhibitor, Accelerates Wound Healing Through Anti-Inflammatory, Antibacterial, and Pro-Regenerative Activities.

Pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Oct 2, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K

Drug Properties Prediction Based on Deep Learning.

Soyoung Yoo1, Junghyun Kim1,2, Guang J Choi2,3

  • 1Department of Bigdata Engineering, Soonchunhyang University, Asan-si 31538, Korea.

Pharmaceutics
|February 26, 2022
PubMed
Summary
This summary is machine-generated.

New deep learning models enhance drug formulation prediction for oral dissolving drugs. Techniques like PCA and WGAN improve accuracy for oral fast disintegrating films and sustained-release tablets, overcoming data limitations.

Keywords:
Wasserstein GANdeep learningimbalanced datapharmaceutical formulationprincipal component analysissmall data

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Related Experiment Videos

Last Updated: Oct 2, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Area of Science:

  • Pharmaceutical Sciences
  • Computational Chemistry
  • Drug Delivery Systems

Background:

  • Deep learning models show promise in predicting drug formulation properties, outperforming traditional machine learning.
  • Existing deep learning approaches struggle with imbalanced, small datasets and suboptimal neural network architectures, hindering prediction accuracy.
  • Predicting disintegration time for oral fast disintegrating films (OFDF) and dissolution profiles for sustained-release matrix tablets (SRMT) remains challenging.

Purpose of the Study:

  • To develop advanced deep learning models for accurate prediction of OFDF disintegration time and SRMT dissolution profiles.
  • To address performance degradation caused by small, imbalanced datasets and inefficient network structures in pharmaceutical formulation prediction.
  • To introduce novel methodologies, including Principal Component Analysis (PCA) and Wasserstein Generative Adversarial Networks (WGAN), for enhanced predictive modeling.

Main Methods:

  • For OFDF, Principal Component Analysis (PCA) was employed to reduce dataset dimensionality, aiming to improve prediction performance and decrease training duration.
  • For SRMT, a Wasserstein Generative Adversarial Network (WGAN) was utilized to generate synthetic data, overcoming limitations posed by scarce experimental data.
  • These deep learning models were specifically designed to maximize prediction accuracy for key pharmaceutical formulation parameters.

Main Results:

  • The proposed PCA-based method significantly improved prediction performance and reduced training time for OFDF disintegration time.
  • The WGAN-based approach effectively addressed the challenge of limited experimental data for SRMT, leading to improved predictive modeling.
  • Experimental results demonstrated that the developed deep learning models outperformed existing methods across all evaluated performance metrics.

Conclusions:

  • The study successfully developed novel deep learning models for pharmaceutical formulation prediction, enhancing accuracy for OFDF and SRMT.
  • The integration of PCA and WGAN represents a significant advancement in overcoming data limitations and improving predictive capabilities in drug formulation.
  • The proposed methods offer a robust and efficient approach for predicting critical drug formulation parameters, paving the way for optimized drug development.